Target intelligence / Profile preview

Hepatitis C virus RNA replication complex

Molecular classification
Other (viral multi-protein complex), Enzyme complex (includes protease, polymerase, others), RNA-dependent RNA polymerase complex
01

Overview

The **Hepatitis C virus RNA replication complex** refers to a multi-protein assembly formed on rearranged host-cell endoplasmic reticulum membranes, sometimes called “membranous webs,” which is essential for amplification of the HCV RNA genome. This complex contains key non-structural proteins synthesized from a polyprotein precursor, primarily **NS3/4A protease**, **NS5A phosphoprotein**, **NS4B scaffolding protein**, and the **NS5B RNA-dependent RNA polymerase**. The main function of the complex is to catalyze the synthesis of complementary negative-strand RNA, which serves as a template for the production of new viral positive-strand genomes. Formation, activity, and regulation of the replication complex depend on both viral protein–protein and protein–RNA interactions, as well as on the recruitment of specific host-cell factors. The complex is the principal target of direct-acting antivirals (DAAs) that inhibit one or more of the essential enzymatic activities (protease, polymerase, or NS5A interactions), and it plays a central role in maintaining persistent HCV infection, which can result in chronic liver disease and cancer[1][2][5][6][7].

Other names
HCV replication complexHCV replicase complexHepatitis C virus replicase
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerase (NS5B)\nInhibition of NS5A replication complex assembly/function\nInhibition of viral NS3/4A protease required for polyprotein processing and replication complex maturation[2][6][7].

03

Biological functions

Viral RNA replicationViral genome amplificationFormation of replication organellesImmune evasion
04

Disease associations

InfectionChronic hepatitisLiver cirrhosisHepatocellular carcinoma
05

Safety considerations

Emergence of drug resistance (mutations in NS3, NS5A, NS5B)[1][2][6]Variable efficacy across HCV genotypes and patient populationsDrug-drug interactions (as with most direct-acting antiviral therapies)
06

Interacting drugs

Sofosbuvir

8 more in the full profile.

07

Biomarkers

Hepatitis C viral load (HCV RNA in plasma)HCV genotype (for drug selection)Resistance-associated substitutions in NS5A, NS3, NS5B

Beyond the preview

Go deeper on Hepatitis C virus RNA replication complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus RNA replication complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call